Clinical trials
Proteinuria clinical trials
Below are recruiting proteinuria clinical trials, each written for real people, not researchers. We’re tracking 19 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07224776RecruitingPhase 1
Sparsentan for proteinuria from VEGF inhibitor cancer treatment
This trial tests if sparsentan can reduce high levels of protein in the urine caused by VEGF signaling pathway inhibitors (VSPIs), a type of cancer treatment. It may help protect kidney function during cancer therapy.
Boston, MassachusettsAges 18 years+ - NCT05457283RecruitingPhase 3
Finerenone safety study for children with kidney disease
This trial studies how safely finerenone works over 18 months in children and young adults with chronic kidney disease who also take an ACE inhibitor or ARB. It aims to better understand long-term side effects when used together with standard kidney blood-pressure medicines.
Palo Alto, CaliforniaAges 1–18 - NCT04456816RecruitingPhase 2
Drug test for IgA? No—anti-PLA2R positive immune kidney disease
This Phase 2 trial studies AP1189 in people with a specific immune-related kidney disease called iMN and very high urine protein. It aims to see whether the drug is safe and tolerable and if it can reduce protein in the urine.
AarhusAges 18–85 - NCT06867471Recruiting
Ketone drink study for kidney disease patients
This study tests if a ketone supplement can reduce protein in urine and protect kidney function in people with chronic kidney disease or polycystic kidney disease. You drink a special supplement and researchers measure how it affects your kidneys.
Herning, JutlandAges 18 years+ - NCT06942910RecruitingPhase 2
New combination therapy for chronic kidney disease with high proteinuria
This study tests a combination of two drugs (zibotentan and dapagliflozin) compared to dapagliflozin alone in people with chronic kidney disease and high protein in their urine. The goal is to see if the combination works better at protecting your kidneys.
AramilAges 18 years+ - NCT01094327Recruiting
Study protein in urine before and after kidney transplant
This study looks at changes in protein in the urine before and after a kidney transplant. It may help doctors better understand kidney health and monitoring after transplant.
Miami, FloridaAges Up to 25 years - NCT07315191RecruitingPhase 4
Finerenone for IgA vasculitis with mild proteinuria in children
This trial tests if the drug finerenone can help children with IgA vasculitis (HSP nephritis) who have mild protein in their urine. It aims to protect kidney function without using stronger medications like steroids.
Beijing, Beijing MunicipalityAges 3–18 - NCT04752293Recruiting
Study of a kidney blood-pressure system in kids
This study looks at how a kidney-related blood-pressure system works in children and teenagers, comparing those with newly diagnosed primary (no known cause) high blood pressure to those with normal blood pressure. It may help doctors better understand childhood blood-pressure changes and guide future care.
Winston-Salem, North CarolinaAges 7–18 - NCT06115122Recruiting
PEPPI Study: Finding early signs of placental problems in pregnancy
This study looks at blood markers to find women at risk for placental problems during pregnancy. It involves blood tests in early and late pregnancy, and at birth, to see how iron levels and other factors affect the placenta and baby's health.
OuluAges Any age - NCT06162546Recruiting
Registry for resistant nephrotic syndrome in children
This study tracks children with nephrotic syndrome whose kidney disease does not respond to usual treatments. It aims to collect information and samples to better understand resistant forms of the condition.
ViennaAges Up to 75 years - NCT06819826RecruitingPhase 3
Study of SC0062 for IgA Nephropathy with Proteinuria
This trial tests an experimental drug (SC0062 capsule) for people with IgA nephropathy who have protein in their urine. It aims to see if the drug can help reduce kidney damage when added to standard treatments like blood pressure medications.
Guangzhou, Yuexiu DistrictAges 18 years+ - NCT06890143RecruitingPhase 3
Dapagliflozin for kids with genetic kidney disease and protein in urine
This trial tests if dapagliflozin, a medication that lowers blood sugar and protects the kidneys, can reduce protein in the urine of children with inherited kidney disease. It may help preserve kidney function when added to standard blood pressure medication.
Shanghai, Shanghai MunicipalityAges 6–18 - NCT06923709RecruitingPhase 2
Amiloride for slowing kidney disease progression
This trial tests if the drug amiloride can help slow down chronic kidney disease. It may be an option if you have moderate kidney function and high protein in your urine.
OdenseAges 18 years+ - NCT07030894RecruitingPhase 4
Study of Nefecon and Ambrisentan for IgA Nephropathy
This trial tests two medications, Nefecon and Ambrisentan, to see if they can help people with IgA nephropathy, a kidney disease. It may be an option if you have been diagnosed with IgA nephropathy in the last 4 years and have protein in your urine.
Changchun, JilinAges 18–70 - NCT00977977RecruitingPhase 2
Rituximab plus cyclosporine for membranous kidney disease
This trial tests whether rituximab (an immune-targeting medicine) plus cyclosporine (another immune medicine) can better control protein leakage in the urine for people with idiopathic membranous nephropathy. It may help reduce long-lasting kidney damage risk when standard treatments like ACE inhibitor or ARB don’t control the protein level.
Bethesda, MarylandAges 18–90 - NCT02699736Enrolling by invitation
HIV and hepatitis C study in European adults
This study follows people living with HIV who also have hepatitis C antibodies, to better understand how HIV and hepatitis C affect health over time. You may be able to join if you meet the age and enrollment requirements, even if your hepatitis C virus level is currently undetectable.
Buenos AiresAges 16 years+ - NCT02818192Recruiting
Kid-focused study to track kidney issues in type 2 diabetes
This study follows young people with type 2 diabetes to better understand risks for kidney problems over time. It may help researchers find earlier warning signs and improve care for adolescents living with type 2 diabetes.
Winnipeg, ManitobaAges 10–18 - NCT07469059Recruiting
Kidney blood vessel imaging in people with active urine findings
This study uses a special ultrasound technique to look at tiny blood vessels in the kidneys of people with active urinary sediment or protein in their urine. The goal is to better understand kidney damage, and you may be eligible if you're already scheduled for a kidney biopsy.
Erlangen, BavariaAges 18 years+ - NCT07561957Recruiting
Smartphone app to help manage chronic kidney disease
This study tests a smartphone app designed to help people with chronic kidney disease (CKD)—a condition where the kidneys don't filter blood as well as they should—follow the latest medical guidelines. The app aims to make it easier for younger adults to stay on top of their kidney health and treatment.
DublinAges 16–30
Hear when a new Proteinuria trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Proteinuria trials by city
Studies with a site in or near these metro areas.
Proteinuria trials by state
Studies with a site anywhere in these states.
Common questions
- Are there clinical trials for proteinuria?
- Yes. Clin2 currently lists 19 recruiting proteinuria studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a proteinuria trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a proteinuria trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.